Search Results 81-90 of 17226 for ibs

  1. Serum-Derived Bovine Immunoglobulin /Protein Isolate (SBI) 5.0 g Twice Daily on Nutritional Status in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) - Mayo Clinic

    ... Irritable Bowel Syndrome (IBS-D). Print details. Share; Facebook · Twitter ... IBS-D. Participation eligibility. Participant eligibility includes age, gender ...

  2. Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption - Mayo Clinic

    ... IBS-D with Bile Acid Malabsorption. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...

  3. Irritable bowel syndrome - Doctors and departments - Mayo Clinic

    Lifestyle changes can make a big difference when it comes to managing this common GI disorder. Learn more about symptoms, diagnosis and how to handle ...

  4. Housecall: Alcohol - risks, benefits and why moderation is key - Mayo Clinic News Network

    Irritable bowel syndrome (IBS) is a common intestinal problem that affects more than 30 million Americans. ... While IBS is a chronic condition, many ...

  5. Overview - Gastrointestinal Barrier Function Laboratory - Mayo Clinic Research

    The lab studies the roles and functions of the gastrointestinal barrier and microbiota in irritable bowel syndrome (IBS) and other diseases and conditions ...

  6. Identifying Biomarkers for Recurrent CDI and Post-CDI IBS - Mayo Clinic

    difficile infection or post-infectious irritable bowel syndrome. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...

  7. Frequent bowel movements Causes - Mayo Clinic

    Irritable bowel syndrome (IBS). American College of Gastroenterology. https://gi.org/topics/irritable-bowel-syndrome/. Accessed Sept. 10, 2024. Ferri FF ...

  8. Madhusudan Grover, M.B.B.S. - Mayo Clinic Faculty Profiles

    Postinfectious irritable bowel syndrome. Gastrointestinal infections affect 1 in 6 people in the U.S. every year and can result in development of IBS , also ...

  9. A Study to Evaluate the Effectiveness and Safety of Vibegron Administered Orally for 12 Weeks to Women with Irritable Bowel Syndrome - Mayo Clinic

    A Study to Evaluate the Effectiveness and Safety of Vibegron Administered Orally for 12 Weeks to Women with Irritable Bowel Syndrome · Share · Facebook · Twitter.

  10. Microbial composition in twins with Irritable bowel syndrome - Mayo Clinic

    ... (IBS) based on the Rome III criteria and to determine fecal microbiota changes in concordant and discordant twins with IBS. Participation eligibility.